Alphabet Inc.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-02
Total Holdings
44
Total Value
1577003761
Accession Number
0001652044-25-000045
Form Type
13F-HR
Manager Name
Alphabet Inc.
Data Enrichment
93% identified
41 identified3 unidentified

Holdings

44 positions
Manager:
Search and click to pin securities to the top
Page 2 of 2
Relay Therapeutics, Inc.
Shares:
1568753(+0.0%)
Value:
$4.1B(-36.4%)
Dianthus Therapeutics, Inc. /DE/
Shares:
208697(+0.0%)
Value:
$3.8B(-16.8%)
Lyell Immunopharma, Inc.
Shares:
5865125(+0.0%)
Value:
$3.2B(-15.6%)
GeneDx Holdings Corp.
Shares:
22711(+0.0%)
Value:
$2.0B(+15.2%)
Foghorn Therapeutics Inc.
Shares:
500901(+0.0%)
Value:
$1.8B(-22.7%)
TScan Therapeutics, Inc.
Shares:
1077080(+0.0%)
Value:
$1.5B(-54.6%)
Barinthus Biotherapeutics plc.
Shares:
1513644(+0.0%)
Value:
$1.5B(-19.8%)
Kronos Bio, Inc.
Shares:
1438232(+0.0%)
Value:
$1.2B(-12.6%)
Autolus Therapeutics plc
Shares:
698262(+0.0%)
Value:
$1.1B(-34.0%)
EXACT SCIENCES CORP
Shares:
23205(+0.0%)
Value:
$1.0B(-23.0%)
Taysha Gene Therapies, Inc.
Shares:
640882(+0.0%)
Value:
$890.8M(-19.6%)
FRACTYL HEALTH, INC.
Shares:
662584(+0.0%)
Value:
$788.5M(-42.2%)
Hyperfine, Inc.
Shares:
898720(+0.0%)
Value:
$647.1M(-18.2%)
Spero Therapeutics, Inc.
Shares:
889979(+0.0%)
Value:
$640.8M(-30.1%)
Rani Therapeutics Holdings, Inc.
Shares:
448492(+0.0%)
Value:
$565.1M(-8.0%)
Tenaya Therapeutics, Inc.
Shares:
915705(+0.0%)
Value:
$522.0M(-60.1%)
Quince Therapeutics, Inc.
Shares:
189122(+0.0%)
Value:
$251.5M(-28.9%)
Alector, Inc.
Shares:
175866(+0.0%)
Value:
$216.3M(-34.9%)
REPLIGEN CORP
Shares:
383(+0.0%)
Value:
$48.7M(-11.7%)
Fulcrum Therapeutics, Inc.
Shares:
14262(+0.0%)
Value:
$41.1M(-38.9%)